Business ❯ Pharmaceutical Industry

Clinical Trials

Drug Development Regulatory Affairs Regulatory Approval Drug Approval Process Vaccine Development Drug Approval Investment Drug Efficacy Regulatory Submissions FDA Approvals FDA Approval Process Drug Candidates Weight Loss Drugs

Eupraxia Reports Early EoE Trial Data With Near‑Normal Tissue at Top Dose

Open‑label Phase 1b/2a findings are guiding a randomized Phase 2b now enrolling that is slated to deliver top‑line data in Q3 2026.

FDA Clears Arrowhead’s Redemplo for FCS, Marking the Biotech’s First Approval

Pluvicto Added to Standard Care Extends rPFS in PSMA-Positive Metastatic Hormone-Sensitive Prostate Cancer

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch

FDA Halts Rocket’s RP-A501 Gene Therapy for Danon Disease After Patient’s Death